Du Y - Search Results

Year	Number of Results
1961	2
1963	3
1964	1
1965	1
1966	1
1980	3
1981	1
1982	2
1983	4
1984	2
1985	2
1986	6
1987	7
1988	8
1989	3
1990	12
1991	4
1992	8
1993	17
1994	27
1995	26
1996	34
1997	30
1998	27
1999	30
2000	40
2001	35
2002	60
2003	87
2004	100
2005	155
2006	164
2007	181
2008	241
2009	284
2010	358
2011	404
2012	532
2013	626
2014	722
2015	855
2016	922
2017	1086
2018	1298
2019	1527
2020	1626
2021	1926
2022	2310
2023	2359
2024	2678
2025	2846
2026	27

1

Multi-omics investigation of Bisphenol A in gastrointestinal carcinogenesis: a network toxicology and molecular docking approach.

Guan J, Yang K, Chen T, Li Z, Gao Y, Huang Y, Zhou R, Huang Z, Du Y, Li T, Zhuang B, Rong X. Guan J, et al. Among authors: du y. Environ Int. 2025 Sep;203:109785. doi: 10.1016/j.envint.2025.109785. Epub 2025 Sep 8. Environ Int. 2025. PMID: 40939530 Free article.

2

Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4-Targeted Antibody-Drug Conjugate Enfortumab Vedotin in Bladder Cancer.

Wu J, Cheng B, Song Y, Cheng J, Gao H, Luo X, Huang M, Wang F, Du Y, Qin C, Xu T. Wu J, et al. Among authors: du y. Cancer Res. 2025 Oct 9. doi: 10.1158/0008-5472.CAN-25-0024. Online ahead of print. Cancer Res. 2025. PMID: 41066596

3

NLRP3 autophagic degradation disruption in melanocytes contributes to vitiligo development.

Zeng K, Zhu Y, Han Z, Xiong S, Zhao Y, Xiao Z, Xie Y, Jin S, Dong T, Lan L, Liu W, Du Y, Guan C, Yu X, Song X. Zeng K, et al. Among authors: du y. Cell Death Differ. 2025 Sep 11. doi: 10.1038/s41418-025-01578-5. Online ahead of print. Cell Death Differ. 2025. PMID: 40935835

4

Life lies in movement.

Yi J, Du Y. Yi J, et al. Among authors: du y. Life Med. 2025 Jul 2;4(5):lnaf024. doi: 10.1093/lifemedi/lnaf024. eCollection 2025 Oct. Life Med. 2025. PMID: 41089669 Free PMC article. No abstract available.

5

National assessments in verse.

Ismail R, Guzovsky AB, Gameiro GR, Amorim da Silva CF, Strielkowski W, Khalifa SF, Weissenborn LM, Erfani E, Hamama R, Alhussein A, Abagat C, Plaza JA, Donoso MR, Du Y, Valdivieso-Mora E, Gupta A, Demoncheaux E, Tsiroukis F, Shawah'en A, Guerrero Gutiérrez OX, Shi J, Gerarduzzi C, Ullah J, Zhang H, Pokharel P, Saeed M, Mahla RS, Pollard R. Ismail R, et al. Among authors: du y. Science. 2025 Oct 2;390(6768):22-23. doi: 10.1126/science.aec2579. Epub 2025 Oct 2. Science. 2025. PMID: 41037618 No abstract available.

6

Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial.

Chen Z, Yang F, Jiang Z, Sun L, Wu L, Han Z, Fan Y, Zhao Y, Li X, Xu H, Meng X, Liu Y, Zhang Z, Luo H, Ma X, Ma X, Shi Q, Zhang Z, Yang R, Wang P, Pan P, Ai X, Li J, Pu X, Wang Z, Fang J, He M, He Y, Guo S, Li J, Wang H, Zhang J, Chu Q, Liu X, Ying S, Wu H, Sun H, Ji Y, Zhou M, Cao C, Tang K, Li Z, Li D, Zhang Z, Li J, Zhou J, Yang H, Du Y, Yang H, Shi J, Chen H, Li W, Lu D, Hu M, Maxwell Wang Z, Li B, Xia M, Lu S. Chen Z, et al. Among authors: du y. Lancet. 2025 Nov 1;406(10515):2078-2088. doi: 10.1016/S0140-6736(25)01848-3. Epub 2025 Oct 19. Lancet. 2025. PMID: 41125109 Clinical Trial.

7

Emerging insights into lineage plasticity in pancreatic cancer initiation, progression, and therapy resistance.

Zhang X, Du Y, Behrens A, Lan L. Zhang X, et al. Among authors: du y. Dev Cell. 2025 Sep 22;60(18):2391-2406. doi: 10.1016/j.devcel.2025.07.002. Dev Cell. 2025. PMID: 40987275 Free article. Review.

8

Editorial: Prevalence and transmission of emerging and replicating animal viruses.

Kayesh MEH, Kong N, Liangliang L, Du Y, Gil da Costa RM. Kayesh MEH, et al. Among authors: du y. Front Cell Infect Microbiol. 2025 Sep 9;15:1683873. doi: 10.3389/fcimb.2025.1683873. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40995221 Free PMC article. No abstract available.

9

CDK1-mediated phosphorylation of LDHA fuels mitosis through LDHB-dependent lactate oxidation.

Liu M, Cheng A, You W, Wu J, Dai C, Wang T, Wu Y, Zhong F, Shi J, Du Y, Hou Z, Gao P, Ruan K, Yang Y, Zhao Y, Zhang K, Yang Z, Guo J. Liu M, et al. Among authors: du y. EMBO Rep. 2025 Oct;26(20):4923-4949. doi: 10.1038/s44319-025-00573-8. Epub 2025 Sep 12. EMBO Rep. 2025. PMID: 40940446 Free PMC article.

10

Ionizable Coenzyme-Engineered Lipid/Fiber Microplexes Boost Ribosomal Translation to Improve mRNA Therapy for Degenerative Diseases.

Ling S, Zhang Y, Chen Y, He W, Wu T, Wang J, Wei Y, Lu M, Zhao WL, Li Q, Du Y, Cui W. Ling S, et al. Among authors: du y. Adv Mater. 2025 Oct 8:e13720. doi: 10.1002/adma.202513720. Online ahead of print. Adv Mater. 2025. PMID: 41058519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,269 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,269 results

Results by year